E-ISSN 2231-3206 | ISSN 2320-4672
 

Case Report 


Escitalopram-induced hyponatremia

Anjana Thomas, Teena C Abraham, Greeshma James, Naveen Kumar Panicker.

Abstract
Escitalopram is an antidepressant belonging to the class of selective serotonin reuptake inhibitors. It is effective in the treatment of generalized anxiety and major depressive disorders. It also has an off-labeled use of treating mild agitation associated with dementia in non-psychotic patients. The most common adverse effects of escitalopram are a headache, fatigue, and diarrhea. Escitalopram-induced hyponatremia is rare; it is seen in elderly, especially in women. This is a rare case of escitalopram-induced hyponatremia which was observed in a 73-year-old female patient who was admitted, with complaints of increased tension and palpitation, in the psychiatry department. She also had a history of asthma for the past 30 years, a surgery done for carpel tunnel syndrome 6 years back and had no history of liver or renal disease. Tablet Nexito (escitalopram) 10 mg 1-0-0 was started as an antidepressant, and after 1 day, she developed fatigue due to hyponatremia which was evident from the laboratory values of sodium. The sodium level was found to be 122.3 mmol/l, the normal range is between 135 and 145 mmol/l. Hence, she was advised to include 2 g of salt in her diet. As she had hyponatremia, NS 3% was added, and also her dose of escitalopram was decreased to 5 mg OD, resulting in a gradual increase in the sodium level. This case showed a causality score of 8 according to Naranjo Scale and the causality to be probable.

Key words: Escitalopram; Hyponatremia; Depression; Antidepressent


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Anjana Thomas
Articles by Teena C Abraham
Articles by Greeshma James
Articles by Naveen Kumar Panicker
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Anjana Thomas, Teena C Abraham, Greeshma James, Naveen Kumar Panicker. Escitalopram-induced hyponatremia. Natl J Physiol Pharm Pharmacol. 2017; 7(12): 1441-1443. doi:10.5455/njppp.2017.7.0620212072017


Web Style

Anjana Thomas, Teena C Abraham, Greeshma James, Naveen Kumar Panicker. Escitalopram-induced hyponatremia. https://www.njppp.com/?mno=271698 [Access: June 02, 2022]. doi:10.5455/njppp.2017.7.0620212072017


AMA (American Medical Association) Style

Anjana Thomas, Teena C Abraham, Greeshma James, Naveen Kumar Panicker. Escitalopram-induced hyponatremia. Natl J Physiol Pharm Pharmacol. 2017; 7(12): 1441-1443. doi:10.5455/njppp.2017.7.0620212072017



Vancouver/ICMJE Style

Anjana Thomas, Teena C Abraham, Greeshma James, Naveen Kumar Panicker. Escitalopram-induced hyponatremia. Natl J Physiol Pharm Pharmacol. (2017), [cited June 02, 2022]; 7(12): 1441-1443. doi:10.5455/njppp.2017.7.0620212072017



Harvard Style

Anjana Thomas, Teena C Abraham, Greeshma James, Naveen Kumar Panicker (2017) Escitalopram-induced hyponatremia. Natl J Physiol Pharm Pharmacol, 7 (12), 1441-1443. doi:10.5455/njppp.2017.7.0620212072017



Turabian Style

Anjana Thomas, Teena C Abraham, Greeshma James, Naveen Kumar Panicker. 2017. Escitalopram-induced hyponatremia. National Journal of Physiology, Pharmacy and Pharmacology, 7 (12), 1441-1443. doi:10.5455/njppp.2017.7.0620212072017



Chicago Style

Anjana Thomas, Teena C Abraham, Greeshma James, Naveen Kumar Panicker. "Escitalopram-induced hyponatremia." National Journal of Physiology, Pharmacy and Pharmacology 7 (2017), 1441-1443. doi:10.5455/njppp.2017.7.0620212072017



MLA (The Modern Language Association) Style

Anjana Thomas, Teena C Abraham, Greeshma James, Naveen Kumar Panicker. "Escitalopram-induced hyponatremia." National Journal of Physiology, Pharmacy and Pharmacology 7.12 (2017), 1441-1443. Print. doi:10.5455/njppp.2017.7.0620212072017



APA (American Psychological Association) Style

Anjana Thomas, Teena C Abraham, Greeshma James, Naveen Kumar Panicker (2017) Escitalopram-induced hyponatremia. National Journal of Physiology, Pharmacy and Pharmacology, 7 (12), 1441-1443. doi:10.5455/njppp.2017.7.0620212072017